Skip to content
Join our Newsletter

BIV on Global: Archegos causes chaos; AbCellera revenue surges

Correction: AbCellera is working on a COVID-19 treatment, not a vaccine. The antibody therapy has been approved for use in 15 countries. More information is available here .

Correction: AbCellera is working on a COVID-19 treatment, not a vaccine. The antibody therapy has been approved for use in 15 countries. More information is available here.